share_log

Barclays Maintains Overweight on Alvotech, Lowers Price Target to $18

Benzinga ·  Jul 25 20:23  · Ratings

Barclays analyst Balaji Prasad maintains Alvotech (NASDAQ:ALVO) with a Overweight and lowers the price target from $22 to $18.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment